New York in $500 million de Blasio-backed biotech boost
December 14, 2016Manufacturing and Production, Research and Development New York, biotech, funding
Mayor of New York, Bill de Blasio, has announced a $500 million initiative to drive the development of the biotech …
Sanofi eyes Actelion merger as J&J backs down
December 14, 2016Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi
After days of negotiations, Johnson and Johnson has stepped down from its attempts to acquire Swiss blood-pressure specialist Actelion, while …
Obama seals $6.3 billion 21st Century Cures Act
December 14, 2016Medical Communications, Research and Development Biden, Obama, US, congress
President Barack Obama put pen to paper on the 21st Century Cures Act on 13 December, which commits to investing …
Lilly offers insulin at 40% discount
December 13, 2016Research and Development, Sales and Marketing Blink Health, Eli Lilly
Eli Lilly has announced that it will offer its insulin medication, including Humalog, at a 40% discount for eligible patients …
Specialist medical education company, Wave, has made six new appointments to reflect the growth in their business over the last 3 months.
December 13, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Becky Robbins, a former Healthcare Analyst at GlobalData, and Lorna Bosdet, formerly Account Executive at Sciterion have joined as Senior …
Alexion loses CEO & CFO as internal investigation continues
December 13, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion
Alexion Pharmaceuticals has revealed that its CEO David Hallal (pictured) and CFO Vikas Sinha have resigned effective immediately in connection …
Medicity in £1.4 million expansion in boost for life sciences
December 13, 2016Manufacturing and Production BioCity, Boots, medicity
Medicity has announced that it has managed to raise the funds to refurbish an additional 29,800 square feet of space, …
Major fire ravages Biocon subsidiary complex in India
December 13, 2016Manufacturing and Production Biocon, Syngene
A subsidiary of Indian biopharmaceutical firm Biocon was gutted by a major fire at Electronic City, Bangalore on 12 December, …
Sun Pharma’s Halol plant’s leaky roof irks FDA
December 13, 2016Manufacturing and Production FDA, Sun Pharma, inspection
The FDA’s two week inspection of Sun Pharmaceutical’s Halol plant produced a 14-page report, with some criticisms reserved for poorly …
Alexion loses CEO & CFO as internal investigation continues
December 12, 2016Business Services, Manufacturing and Production, Medical Communications
Alexion Pharmaceuticals has revealed that its CEO David Hallal and CFO Vikas Sinha have resigned effective immediately in connection with …
Scottish Medicines Consortium approves Sanofi’s prostate cancer drug
December 12, 2016Manufacturing and Production, Sales and Marketing Jevtana, Sanofi, prostate cancer
Sanofi’s speciality care global business unit Sanofi Genzyme has announced that the Scottish Medicines Consortium has accepted the company’s Jevtana …
Rare challenges: Meeting patient needs and delivering medical innovation in ultra-rare diseases
December 12, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, ultra rare disease, ultra-rare disease
Dr Emma Harvey, senior medical director at Alexion Pharmaceuticals UK, shares her views on the challenges of working in the …
Personalised leukaemia vaccine shows promise in new trial
December 12, 2016Sales and Marketing leukaemia
A personalised cancer vaccine has proven to have significant efficacy in the treatment of acute myeloid leukaemia (AML), researchers at …
Phase 3 eye drug combo failure for Novartis
December 12, 2016Research and Development, Sales and Marketing Novartis, ophthotech
Novartis’ has failed in its attempt to expand the applications of its anti-VEGF eye treatment Lucentis (ranibizumab) after the drug …
Neurodegenerative market to be worth $45 billion by 2022
December 12, 2016Sales and Marketing Biogen, GBI Research, Novartis, Roche, Sanofi, neurodegenerative
Neurodegenerative disorders including Alzheimer’s, Parkinson’s, Huntington’s, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) form a lucrative worldwide market which …
First generic copy of Roche’s Tamiflu hits US market
December 12, 2016Sales and Marketing Alvogen, Roche, Tamiflu
Drugmaker Alvogen has released the first generic version of Roche’s flu medication Tamiflu (oseltamivir) in the US, where it expects …
AZ and Lilly come together to battle Alzheimer’s
December 9, 2016Research and Development, Sales and Marketing AZ, lilly
Pharma titans Eli Lilly and AstraZeneca have announced they are to join forces to co-develop a potential Alzheimer’s treatment, currently …
Top Ten most popular articles on Pharmafile.com this week
December 9, 2016Medical Communications top ten
Christmas is drawing ever closer, but that doesn’t mean the industry is slowing down. This week, features from the latest …
AZ to terminate 700 US jobs
December 9, 2016Manufacturing and Production, Medical Communications AstraZeneca, job cuts
AstraZeneca has revealed that it plans to cut 700 positions across the US by 10 February 2017, including 120 positions …
Top Pharmaceutical Markets 2016: China
December 9, 2016Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing China, market analysis
Originally featured in Pharmafile Autumn 2016, a report from the United States International Trade Administration sheds light on the Chinese …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
